About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITING

Prospective Study on ICG Lymphoscintigraphy Changes Before and After Radiotherapy in Breast Cancer Patients

NCT07297927•Inah Kim

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Breast NeoplasmsLymphedema Due to Radiation

Locations

1

South Korea

Locations (1)

Dongtan Sacred Heart Hospital

Hwaseong-si, Gyeonggido, South Korea

Key Dates

Start Date

November 5, 2025

Primary Completion Date

February 28, 2026

Completion Date

October 18, 2028

Last Updated

December 22, 2025

Related Studies

Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery

NCT06608446

Breast Neoplasms

RECRUITINGPhase 1/2

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

NCT04895709

Cervical CancerGastric/Gastroesophageal Junction Adenocarcinoma+9 more

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

NCT07191730

CardiotoxicityHeart Failure+2 more

RECRUITINGPhase 3

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT06312176

Breast Neoplasms

RECRUITINGPhase 2

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

NCT06797635

Breast NeoplasmsBreast Cancer

Evaluation of Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer Patients

NCT07003841

Breast Neoplasms

View all related studies

Contacts

Inah Kim, M.D.,Ph.D

CONTACT

82-10-2937-6852 inahsylvia@gmail.com

Yongkyun Jung, M.D.

CONTACT

82-10-3681-7243 andnfn@naver.com

Sponsors

Lead Sponsor

Inah Kim

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions